Under the auspices of
Jan 14-16, 2027 in Phoenix, AZ
ORGANIZING COMMITTEE
The 2027 meeting is hosted by Alliance for Laboratory Medicine Innovation (ALMI), supported by Foundation for Laboratory Medicine Innovation (FLMI).
Meeting Chair: Zhen Zhao, PhD, DABCC, Weill Cornell Medicine
Executive Chair: Jing Cao, PhD, DABCC, University fo Texas Southwestern Medical Center
Scientific Chair: Xin Yi, PhD, DABCC, Houston Methodist Hospital
Program Planning and Strategic Chair: Min Yu, MD, PhD, MBA, DABCC, Harvard Beth Israel Deaconess Medical Center
Section Chairs:
Genomics and Personalized Diagnostics: Zhenya Tang, MD, PhD, FACMG, University of Nebraska Medical Center
Transplant Precision Medicine: Dongfeng Chen, PhD, F(ACHI), Duke University Medical Center
Drug Use and Misuse: Yanwei Xi, DABMGG, FACMG, Children's Hospital of Eastern Ontario;
Fang Wu, PhD, DABCC, Harvard Brigham and Women’s Hospital
Navigating the Path to Commercialization: Tony Ye Hu, PhD, Tsinghua University
From AI to Advanced Diagnostics: Sabrina Racine-Brzostek, MD, Weill Cornell Medicine
Human Microbiome and Infectious Disease: Chao Wang, PhD, Arizona State University
Yiwei Tang, MD, PhD, Chongqing Medical University
From Technology to Clinical Solutions: Lingjun Li, PhD, The University of Wisconsin-Madison
Commercial Laboratory: Genomics in Oncology: Xie Heng, PhD, MBA, Delve Bio
At-Home and Direct to Consumer Testing: Nicole Tolan, PhD, DABCC, Washington University
The Global Future of Diagnostics: A Leadership Perspective: Damien Gruson, PhD, Universitaires Saint-Luc
Cardiac Health & Chronic Disease Monitoring: Jing Cao, PhD, DABCC, University fo Texas Southwestern Medical Center